MANGOCEUTICALS INC
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
MGRX$0.20+1.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| March 31, 2024 | December 31, 2023 | |
|---|---|---|
| ASSETS | ||
| CURRENT ASSETS | ||
| Cash and cash equivalents | $15,305 | $739,006 |
| Inventory | 14,452 | 18,501 |
| Prepaid expenses - related party | 60,051 | 60,953 |
| TOTAL CURRENT ASSETS | 89,808 | 818,460 |
| FIXED ASSETS | ||
| Property and equipment, net of accumulated depreciation of $34,976 and $28,752 | 89,905 | 96,129 |
| TOTAL FIXED ASSETS | 89,905 | 96,129 |
| OTHER ASSETS | ||
| Deposits | 16,942 | 16,942 |
| Right of use - asset | 104,792 | 119,262 |
| TOTAL OTHER ASSETS | 121,734 | 136,204 |
| TOTAL ASSETS | $301,447 | $1,050,793 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||
| CURRENT LIABILITIES | ||
| Accounts payable and accrued liabilities | $1,015,945 | $140,765 |
| Accounts payable and accrued liabilities - related parties | 35,000 | - |
| Payroll tax liabilities | 8,203 | 6,595 |
| Notes payable to related parties | 87,500 | - |
| Right-of-use liability - operating lease | 65,554 | 63,718 |
| TOTAL CURRENT LIABILITIES | 1,212,202 | 211,078 |
| LONG-TERM LIABILITIES | ||
| Right-of-use liability - operating lease | 47,713 | 64,961 |
| TOTAL LONG-TERM LIABILITIES | 47,713 | 64,961 |
| TOTAL LIABILITIES | 1,259,915 | 276,039 |
| COMMITMENTS AND CONTINGENCIES (SEE NOTE 10) | - | - |
| STOCKHOLDERS’ EQUITY (DEFICIT) | ||
| Common stock (par value $0.0001, 200,000,000 shares authorized, of which 23,619,500 and 21,419,500 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively) | 2,362 | 2,142 |
| Additional paid in capital | 12,635,030 | 12,000,785 |
| Accumulated deficit | (13,595,754) | (11,228,173) |
| Accumulated other comprehensive loss | (70) | - |
| TOTAL STOCKHOLDERS’ EQUITY(DEFICIT) | (958,432) | 774,754 |
| Non-controlling interest | (36) | - |
| TOTAL STOCKHOLDERS’ EQUITY(DEFICIT) | (958,468) | 774,754 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | $301,447 | $1,050,793 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.